Patents by Inventor Jean Paul KESTEMONT

Jean Paul KESTEMONT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of seletalisib
    Patent number: 11059820
    Abstract: Crystalline forms of seletalisib, designated as Form B and Form F and characterized herein, being selective inhibitors of PI3 kinase enzymes, in particular of the human PBK? isoform, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: July 13, 2021
    Assignee: UCB Biopharma SPRL
    Inventors: Luc Lambert Jozef Jan Aerts, Georges Assaf, Nicolas Edmond Carly, Vincent Adolphe Carol Cool, Jean-Pierre Delatinne, Laurent Jacques Willy Delhaye, Jean Paul Kestemont, Sarah Le Meur
  • CRYSTALLINE FORMS OF SELETALISIB
    Publication number: 20200095246
    Abstract: Crystalline forms of seletalisib, designated as Form B and Form F and characterized herein, being selective inhibitors of PI3 kinase enzymes, in particular of the human PBK? isoform, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
    Type: Application
    Filed: May 24, 2018
    Publication date: March 26, 2020
    Inventors: Luc Lambert Jozef Jan AERTS, Georges ASSAF, Nicolas Edmond CARLY, Vincent Adolphe Carol COOL, Jean-Pierre DELATINNE, Laurent Jacques Willy DELHAYE, Jean Paul KESTEMONT, Sarah LE MEUR,